世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5611 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・BCL-2（B細胞リンパ腫2）阻害剤の市場動向 ・企業の競争状況、市場シェア ・BCL-2（B細胞リンパ腫2）阻害剤の種類別市場規模と予測2016-2027（併用療法、単剤療法） ・BCL-2（B細胞リンパ腫2）阻害剤の用途別市場規模と予測2016-2027（がん、自己免疫疾患、その他） ・BCL-2（B細胞リンパ腫2）阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・BCL-2（B細胞リンパ腫2）阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・BCL-2（B細胞リンパ腫2）阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・BCL-2（B細胞リンパ腫2）阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・BCL-2（B細胞リンパ腫2）阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc.、F. Hoffmann-La Roche Ltd.） ・結論

Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.

Market Analysis and Insights: Global BCL-2 (B-cell lymphoma 2) Inhibitors Market
The global BCL-2 (B-cell lymphoma 2) Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global BCL-2 (B-cell lymphoma 2) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global BCL-2 (B-cell lymphoma 2) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global BCL-2 (B-cell lymphoma 2) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global BCL-2 (B-cell lymphoma 2) Inhibitors market.

Global BCL-2 (B-cell lymphoma 2) Inhibitors Scope and Market Size
BCL-2 (B-cell lymphoma 2) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global BCL-2 (B-cell lymphoma 2) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Combination therapy
Monotherapy

Segment by Application
Cancer
Auto-immune diseases
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie Inc.
F. Hoffmann-La Roche Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Combination therapy
1.2.3 Monotherapy
1.3 Market by Application
1.3.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cancer
1.3.3 Auto-immune diseases
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Perspective (2016-2027)
2.2 BCL-2 (B-cell lymphoma 2) Inhibitors Growth Trends by Regions
2.2.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 BCL-2 (B-cell lymphoma 2) Inhibitors Industry Dynamic
2.3.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Trends
2.3.2 BCL-2 (B-cell lymphoma 2) Inhibitors Market Drivers
2.3.3 BCL-2 (B-cell lymphoma 2) Inhibitors Market Challenges
2.3.4 BCL-2 (B-cell lymphoma 2) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Revenue
3.1.1 Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue
3.4 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Concentration Ratio
3.4.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2020
3.5 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players Head office and Area Served
3.6 Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Product Solution and Service
3.7 Date of Enter into BCL-2 (B-cell lymphoma 2) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 BCL-2 (B-cell lymphoma 2) Inhibitors Breakdown Data by Type
4.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Type (2022-2027)

5 BCL-2 (B-cell lymphoma 2) Inhibitors Breakdown Data by Application
5.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2016-2027)
6.2 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type
6.2.1 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2027)
6.3 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application
6.3.1 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2027)
6.4 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country
6.4.1 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2016-2027)
7.2 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type
7.2.1 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2027)
7.3 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application
7.3.1 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2027)
7.4 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country
7.4.1 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type
8.2.1 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application
8.3.1 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Region
8.4.1 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2016-2027)
9.2 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type
9.2.1 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application
9.3.1 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country
9.4.1 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type
10.2.1 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application
10.3.1 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country
10.4.1 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
11.1.4 AbbVie Inc. Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2016-2021)
11.1.5 AbbVie Inc. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Combination therapy
Table 3. Key Players of Monotherapy
Table 4. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2016-2021)
Table 8. Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2022-2027)
Table 10. BCL-2 (B-cell lymphoma 2) Inhibitors Market Trends
Table 11. BCL-2 (B-cell lymphoma 2) Inhibitors Market Drivers
Table 12. BCL-2 (B-cell lymphoma 2) Inhibitors Market Challenges
Table 13. BCL-2 (B-cell lymphoma 2) Inhibitors Market Restraints
Table 14. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors as of 2020)
Table 17. Ranking of Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Product Solution and Service
Table 21. Date of Enter into BCL-2 (B-cell lymphoma 2) Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Inc. Company Details
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. BCL-2 (B-cell lymphoma 2) Inhibitors Product
Table 64. AbbVie Inc. Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. F. Hoffmann-La Roche Ltd. Company Details
Table 67. F. Hoffmann-La Roche Ltd. Business Overview
Table 68. F. Hoffmann-La Roche Ltd. BCL-2 (B-cell lymphoma 2) Inhibitors Product
Table 69. F. Hoffmann-La Roche Ltd. Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd. Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Combination therapy Features
Figure 3. Monotherapy Features
Figure 4. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Cancer Case Studies
Figure 6. Auto-immune diseases Case Studies
Figure 7. Other Case Studies
Figure 8. BCL-2 (B-cell lymphoma 2) Inhibitors Report Years Considered
Figure 9. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions: 2020 VS 2027
Figure 12. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2022-2027)
Figure 13. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Players in 2020
Figure 14. Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors as of 2020
Figure 15. The Top 10 and 5 Players Market Share by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2020
Figure 16. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 17. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Type (2022-2027)
Figure 18. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2016-2027)
Figure 20. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2016-2027)
Figure 21. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Country (2016-2027)
Figure 22. United States BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2016-2027)
Figure 26. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2016-2027)
Figure 27. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Country (2016-2027)
Figure 28. Germany BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2016-2027)
Figure 36. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2016-2027)
Figure 37. Asia-Pacific BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Region (2016-2027)
Figure 38. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2016-2027)
Figure 46. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2016-2027)
Figure 47. Latin America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Country (2016-2027)
Figure 48. Mexico BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2016-2027)
Figure 52. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2016-2027)
Figure 53. Middle East & Africa BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Country (2016-2027)
Figure 54. Turkey BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Inc. Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2016-2021)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

---